Progressive Multifocal Leukoencephalopathy in a Heart Transplant Recipient Following Rituximab Therapy for Antibody‐Mediated Rejection

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-6143|13|4|1075-1079

ISSN： 1600-6135

Source： AMERICAN JOURNAL OF TRANSPLANTATION, Vol.13, Iss.4, 2013-04, pp. : 1075-1079

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravenous immunoglobulins and rituximab therapy for severe transplant glomerulopathy in chronic antibody‐mediated rejection: a pilot study

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 5, 2015-05 ,pp. : 439-446

John Wiley & Sons Inc

Access to resources Recommend Favorite

Progressive Multifocal Leukoencephalopathy in a HIV-Negative Patient with Small Lymphocytic Leukemia following Treatment with Rituximab

By  

Case Reports in Oncology, Vol. 4, Iss. 1, 2011-03 ,pp. : 136-142

Karger

Access to resources Recommend Favorite

Eculizumab Salvage Therapy for Antibody‐Mediated Rejection in a Desensitization‐Resistant Intestinal Re‐Transplant Patient

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 7, 2015-07 ,pp. : 1995-2000

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of antibody‐mediated rejection in renal transplant patients: a clinical practice survey

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 2, 2015-02 ,pp. : 118-123

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Survey of Current Practice for Antibody‐Mediated Rejection in Heart Transplantation

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 13, Iss. 4, 2013-04 ,pp. : 1069-1074

John Wiley & Sons Inc

Access to resources Recommend Favorite